Evidence map›Paper›PMID 42672905›Full record

ArticleChemistry & biodiversity2026

Antiglycation and Amyloid-β Inhibitory Activities of Pandanus odorifer Extracts and Isolated Constituents: In Vitro and Molecular Docking Insights.

Patricia Marie P Oliva, Sarleen G Castro, Joe Anthony H Manzano, Hayato Ishikawa, Mario A Tan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Patricia Marie P OlivaThe Graduate School, University of Santo Tomas, Manila, Philippines.ORCID https://orcid.org/0009-0001-6036-7846
Sarleen G CastroGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.ORCID https://orcid.org/0000-0001-9328-4388
Joe Anthony H ManzanoCollege of Science, University of Santo Tomas, Manila, Philippines.ORCID https://orcid.org/0000-0002-4062-223X
Hayato IshikawaGraduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.ORCID https://orcid.org/0000-0002-3884-2583
Mario A TanThe Graduate School, University of Santo Tomas, Manila, Philippines.ORCID https://orcid.org/0000-0002-0422-8120

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder associated with amyloid-β (Aβ) aggregation, advanced glycation end products (AGEs), and oxidative stress. This study investigated the antiglycation, antioxidant, anti-amyloidogenic, and predicted drug-likeness properties of Pandanus odorifer (Forssk.) Kuntze. The methanolic crude extract showed high total flavonoid content (121.7 ± 2.50 mg QE/g), moderate total phenolic content (16.61 ± 1.50 mg GAE/g), and strong AGE inhibition (IC

Indexed as

Amyloid beta-PeptidesAntioxidantsGlycation End Products, AdvancedMolecular Docking SimulationPlant ExtractsAcetylcholinesteraseAmyloid Precursor Protein SecretasesAntiglycation AgentsHumansMolecular StructureStructure-Activity RelationshipAcetylcholinesteraseAmyloid beta-PeptidesAmyloid Precursor Protein SecretasesAntiglycation AgentsAntioxidantsGlycation End Products, AdvancedPlant ExtractsAlzheimer's diseaseantioxidantmolecular dockingPandanus odoriferthioflavin T assay

Identifiers

PMID42672905
PMCPMC13529243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.